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Introduction:  
Many hemodialysis patients worldwide receive dialysis via central venous catheters (CVC).  A major cause of CVC 
malfunction is intraluminal thrombosis which decreases or stops the blood flow through the catheter. Tissue 
Plasminogen Activator (TPA) is a thrombolytic agent that has been shown to be effective in treating and preventing 
CVC thrombosis.  
 
Method: 
151 dialysis centres across Canada were surveyed using a standardized questionnaire via email and telephone to 
identify the patterns of TPA usage from April 1, 2012 date to August 31, 2012 date. Dialysis centres were contacted 
twice in follow-up if there was no response to the original survey sent. 
 
Results: 
Fifty-two dialysis centres completed the survey. 92.31% of 52 centers used citrate as the inter-dialytic catheter 
locking solution while 36.54% of the surveyed centers used heparin. All respondents reported using “failure of 
conservative methods” as an indicator for TPA administration. 
 
While 96.15% of centres reported using ‘sluggish blood flow’ as an indicator for TPA administration, there was 
considerable variation in the minimum threshold for that blood flow: 38.46% of centres were using <300, 36.54% of 
centres were using <250, and 15.38% of centres were using <200.   
 
The 2 mg dose of TPA was used by 60.78% of the surveyed dialysis units across Canada for treatment of suspected 
intraluminal thrombosis, compared to 39.22% of units using 1 mg dose. Of note, the province of Quebec reported 
that 73.33% of dialysis centers use a 2 mg dose.   
 
Conclusion: 
The lack of consensus surrounding the minimum blood flow threshold before TPA is indicated suggests that the area 
requires further research and knowledge translation activities.  
 
Table 1: Indications for TPA administration 
  
Indication for TPA Administration % of centres 
Failure of Conservative Methods 100.00% 
Sluggish blood flow 96.15% 
Increase arterial alarm beyond limit 67.31% 
Frequent arterial alarms 75.00% 
Dialysis prescription not met 72.00% 
Anticipating next Dialysis to be difficult or not possible 80.77% 
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